<DOC>
	<DOC>NCT00352261</DOC>
	<brief_summary>The purpose of the study is to compare the treatment of esomeprazole 40 mg once daily and lansoprazole 30 mg once daily in controlling intragastric pH in Barrett's Esophagus patients</brief_summary>
	<brief_title>An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients</brief_title>
	<detailed_description />
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Documented history (within 2 yrs of histologically proven BE; Aged 1870 (inclusive); Willing and able to comply with all study procedures Signs of clinically significant GI bleeding within 3 days prior to randomization; History of gastric or esophageal surgery; Clinically significant illness within 2 weeks prior to first dose of study drug or during study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Barrett's Esophagus</keyword>
</DOC>